Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion

Journal of Immunology

Volumn 181, Issue 2, 2008, Pages 1012-1018

  Li, Xinrui ^a,b   Su, Kaihong ^a   Ji, Chuanyi ^a   Szalai, Alexander J ^a   Wu, Jianming ^a   Zhang, Yan ^a   Zhou, Tong ^a   Kimberly, Robert P ^a,b,c   Edberg, Jeffrey C ^a,c  

^a The University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; AUTOANTIBODY; B CELL ACTIVATING FACTOR; C REACTIVE PROTEIN; FC RECEPTOR; IMMUNOGLOBULIN G; LIGAND; MONOCLONAL ANTIBODY; OPSONIN; FCGR1A PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INNATE IMMUNITY; MODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SURVIVAL; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; METABOLISM; TUMOR CELL LINE;

B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; C-REACTIVE PROTEIN; CELL LINE, TUMOR; CELLS, CULTURED; HUMANS; IMMUNOGLOBULIN G; MYELOID CELLS; OPSONIN PROTEINS; RECEPTORS, IGG;

EID: 49049115395     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.2.1012     Document Type: Article

References (47)

1. Mackay, F., and J. L. Browning. 2002. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2: 465-475. (Pubitemid 37328738)
2. Miller, J. P., J. E. Stadanlick, and M. P. Cancro. 2006. Space, selection, and surveillance: setting boundaries with BLyS. J. Immunol. 176: 6405-6410.
3. Woodland, R. T., M. R. Schmidt, and C. B. Thompson. 2006. BLyS and B cell homeostasis. Semin. Immunol. 18: 318-326.
4. Bossen, C., and P. Schneider. 2006. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18: 263-275. (Pubitemid 44287558)
5. Salzer, U., S. Jennings, and B. Grimbacher. 2007. To switch or not to switch: the opposing roles of TACI in terminal B cell differentiation. Eur. J. Immunol. 37: 17-20. (Pubitemid 46128781)
6. Do, R. K., E. Hatada, H. Lee, M. R. Tourigny, D. Hilbert, and S. Chen-Kiang. 2000. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med. 192: 953-964.
7. Batten, M., J. Groom, T. G. Cachero, F. Qian, P. Schneider, J. Tschopp, J. L. Browning, and F. Mackay. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med. 192: 1453-1466. (Pubitemid 30953883)
8. Rolink, A. G., J. Tschopp, P. Schneider, and F. Melchers. 2002. BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol. 32: 2004-2010. (Pubitemid 34814557)
9. Schiemann, B., J. L. Gommerman, K. Vora, T. G. Cachero, S. Shulga-Morskaya, M. Dobles, E. Frew, and M. L. Scott. 2001. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293: 2111-2114. (Pubitemid 32848063)
10. Jacob, C. O., L. Pricop, C. Putterman, M. N. Koss, Y. Liu, M. Kollaros, S. A. Bixler, C. M. Ambrose, M. L. Scott, and W. Stohl. 2006. Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J. Immunol. 177: 2671-2680.
11. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710. (Pubitemid 30002351)
12. Zhang, J., V. Roschke, K. P. Baker, Z. Wang, G. S. Alarcon, B. J. Fessler, H. Bastian, R. P. Kimberly, and T. Zhou. 2001. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J. Immunol. 166: 6-10. (Pubitemid 32038409)
13. Mariette, X., S. Roux, J. Zhang, D. Bengoufa, F. Lavie, T. Zhou, and R. Kimberly. 2003. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62: 168-171. (Pubitemid 36135394)
14. Groom, J., S. L. Kalled, A. H. Cutler, C. Olson, S. A. Woodcock, P. Schneider, J. Tschopp, T. G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J. Clin. Invest. 109: 59-68. (Pubitemid 34052542)
15. Nardelli, B., O. Belvedere, V. Roschke, P. A. Moore, H. S. Olsen, T. S. Migone, S. Sosnovtseva, J. A. Carrell, P. Feng, J. G. Giri, and D. M. Hilbert. 2001. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97: 198-204. (Pubitemid 32061261)
16. Scapini, P., B. Nardelli, G. Nadali, F. Calzetti, G. Pizzolo, C. Montecucco, and M. A. Cassatella. 2003. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197: 297-302. (Pubitemid 36184236)
17. Gorelik, L., K. Gilbride, M. Dobles, S. L. Kalled, D. Zandman, and M. L. Scott. 2003. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J. Exp. Med. 198: 937-945. (Pubitemid 37152930)
18. Ohata, J., N. J. Zvaifler, M. Nishio, D. L. Boyle, S. L. Kalled, D. A. Carson, and T. J. Kipps. 2005. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J. Immunol. 174: 864-870. (Pubitemid 40094281)
19. Krumbholz, M., D. Theil, T. Derfuss, A. Rosenwald, F. Schrader, C. M. Monoranu, S. L. Kalled, D. M. Hess, B. Serafini, F. Aloisi, et al. 2005. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201: 195-200. (Pubitemid 40189428)
20. Craxton, A., D. Magaletti, E. J. Ryan, and E. A. Clark. 2003. Macrophage- and dendritic cell-dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood 101: 4464-4471. (Pubitemid 36857815)
21. Schneider, P., F. MacKay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189: 1747-1756. (Pubitemid 29272691)
22. Gosselin, E. J., K. Wardwell, D. R. Gosselin, N. Alter, J. L. Fisher, and P. M. Guyre. 1992. Enhanced antigen presentation using human Fc γ receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 149: 3477-3481.
23. Heijnen, I. A., M. J. van Vugt, N. A. Fanger, R. F. Graziano, T. P. de Wit, F. M. Hofhuis, P. M. Guyre, P. J. Capel, J. S. Verbeek, and J. G. van de Winkel. 1996. Antigen targeting to myeloid-specific human Fc γ RI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97: 331-338.
24. Li, X., J. Wu, R. H. Carter, J. C. Edberg, K. Su, G. S. Cooper, and R. P. Kimberly. 2003. A novel polymorphism in the Fcγ receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48: 3242-3252. (Pubitemid 37409339)
25. Liu, W., A. Szalai, L. Zhao, D. Liu, F. Martin, R. P. Kimberly, T. Zhou, and R. H. Carter. 2004. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Arthritis Rheum. 50: 1884-1896. (Pubitemid 38725101)
26. Kilpatrick, J. M., J. F. Kearney, and J. E. Volanakis. 1982. Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies. Mol. Immunol. 19: 1159-1165.
27. Su, K., H. Yang, X. Li, X. Li, A. W. Gibson, J. M. Cafardi, T. Zhou, J. C. Edberg, and R. P. Kimberly. 2007. Expression profile of FcγRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J. Immunol. 178: 3272-3280. (Pubitemid 46333211)
28. Volanakis, J. E., W. L. Clements, and R. E. Schrohenloher. 1978. C-reactive protein: purification by affinity chromatography and physicochemical characterization. J. Immunol. Methods 23: 285-295. (Pubitemid 9041891)
29. Wu, J., J. C. Edberg, P. B. Redecha, V. Bansal, P. M. Guyre, K. Coleman, J. E. Salmon, and R. P. Kimberly. 1997. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J. Clin. Invest. 100: 1059-1070. (Pubitemid 27386289)
30. Du Clos, T. W., and C. Mold. 2004. C-reactive protein: an activator of innate immunity and a modulator of adaptive immunity. Immunol. Res. 30: 261-277.
31. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263. (Pubitemid 29330000)
32. Edberg, J. C., H. Qin, A. W. Gibson, A. M. Yee, P. B. Redecha, Z. K. Indik, A. D. Schreiber, and R. P. Kimberly. 2002. The CY domain of the Fcγ RIa α-chain (CD64) alters γ-chain tyrosine-based signaling and phagocytosis. J. Biol. Chem. 277: 41287-41293.
33. Kurosaka, K., N. Watanabe, and Y. Kobayashi. 2002. Potentiation by human serum of anti-inflammatory cytokine production by human macrophages in response to apoptotic cells. J. Leukocyte Biol. 71: 950-956.
34. van Vugt, M. J., M. J. Kleijmeer, T. Keler, I. Zeelenberg, M. A. van Dijk, J. H. Leusen, H. J. Geuze, and J. G. van de Winkel. 1999. The FcγRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR γ-chain. Blood 94: 808-817.
35. Amigorena, S., C. Bonnerot, J. R. Drake, D. Choquet, W. Hunziker, J. G. Guillet, P. Webster, C. Sautes, I. Mellman, and W. H. Fridman. 1992. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 256: 1808-1812.
36. Muta, T., T. Kurosaki, Z. Misulovin, M. Sanchez, M. C. Nussenzweig, and J. V. Ravetch. 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc γ RIIB modulates B-cell receptor signalling. Nature 368: 70-73. (Pubitemid 24073879)
37. Gross, J. A., S. R. Dillon, S. Mudri, J. Johnston, A. Littau, R. Roque, M. Rixon, O. Schou, K. P. Foley, H. Haugen, et al. 2001. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15: 289-302.
38. Thien, M., T. G. Phan, S. Gardam, M. Amesbury, A. Basten, F. Mackay, and R. Brink. 2004. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity 20: 785-798. (Pubitemid 38757447)
39. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999.
40. Kuhn, S. E., A. Nardin, P. E. Klebba, and R. P. Taylor. 1998. Escherichia coli bound to the primate erythrocyte complement receptor via bispecific monoclonal antibodies are transferred to and phagocytosed by human monocytes in an in vitro model. J. Immunol. 160: 5088-5097.
41. Craig, M. L., A. J. Bankovich, J. L. McElhenny, and R. P. Taylor. 2000. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism. Arthritis Rheum. 43: 2265-2275.
42. Pepys, M. B. 1981. C-reactive protein fifty years on. Lancet 1: 653-657.
43. Jones, S. A., D. Novick, S. Horiuchi, N. Yamamoto, A. J. Szalai, and G. M. Fuller. 1999. C-reactive protein: a physiological activator of interleukin 6 receptor shedding. J. Exp. Med. 189: 599-604.
44. Zouki, C., M. Beauchamp, C. Baron, and J. G. Filep. 1997. Prevention of in vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. J. Clin. Invest. 100: 522-529. (Pubitemid 27340498)
45. Williams, T. N., C. X. Zhang, B. A. Game, L. He, and Y. Huang. 2004. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through FcγRII and extracellular signal-regulated kinase pathway: an implication of CRP involvement in plaque destabilization. Arterioscler. Thromb. Vasc. Biol. 24: 61-66.
46. Woollard, K. J., C. Fisch, R. Newby, and H. R. Griffiths. 2005. C-reactive protein mediates CD11b expression in monocytes through the non-receptor tyrosine kinase, Syk, and calcium mobilization but not through cytosolic peroxides. Inflamm. Res. 54: 485-492.
47. Takai, T. 2005. Fc receptors and their role in immune regulation and autoimmunity. J Clin. Immunol. 25: 1-18. (Pubitemid 40386174)